CR
CHARLES RIVER LABORATORIES
CRL· Health Care· Life Sciences Tools & ServicesS&P 500
Close · 16/09/2026
273.41
1D
+0.19%52-week range
144.26 – 303.31
Volume
10,14,800.00
Price history
CRL
17/08/2026 to 16/09/2026
O 272.78 H 282.91 L 270.88
1W-1.77%
1M-4.62%
3M+47.96%
6M+77.87%
1Y+79.59%
3Y+36.94%
5Y-38.63%
MAX-28.48%
Fundamentals
as of 16/09/2026- Market cap
- $13.05B
- Shares out
- 47.74M
- P/E (forward)
- 21.93
- EPS (trailing)
- -5.00
- Beta
- 1.41
- Profit margin
- -5.96%
- P/B
- 4.60
- Return on equity
- -8.40%
SEC financial statements
60 quarterly and 18 annual periods through 27/06/2026.
Details
- Ticker
- CRL
- Index
- SP500
- Sector
- Health Care
- Industry
- Life Sciences Tools & Services
- HQ
- -
Last close 16/09/2026.
Tracked by Congress
5 filers · 0 on watchlist · 4 buys · 4 sells · D: 4 · R: 4
- 12/05/2025Jefferson ShreveSellCharles River Laboratories International, Inc. Common Stock$15,001–$50,000
- 08/05/2025Jefferson ShreveBuyCharles River Laboratories International, Inc. Common Stock$15,001–$50,000
- 15/05/2025Rob BresnahanSellCharles River Laboratories International, Inc. Common Stock$1,001–$15,000
- 08/04/2025Rob BresnahanBuyCharles River Laboratories International, Inc. Common Stock$15,001–$50,000
- 15/01/2025Julie JohnsonBuyCharles River Laboratories International, Inc. Common Stock$1,001–$15,000
- 08/09/2023Lois FrankelSellCharles River Laboratories International, Inc.$1,001–$15,000
- 25/04/2023Lois FrankelBuyCharles River Laboratories International, Inc.$1,001–$15,000
- 25/08/2022Zoe LofgrenSellCharles River Laboratories International, Inc.$1,001–$15,000